Parnax Lab LtdPharmaceuticalsINE383L01019
Valuation
Market Cap₹143.91 Cr
TTM PE95.65x
Forward PE106.79x
PEG0.74
Book Value₹737.06
P/B0.17x
TTM EPS₹1.31
Fwd EPS₹1.17
TTM Revenue₹7.23 Cr
TTM PAT₹0.77 Cr
TTM EBITDA₹-1.07 Cr
TTM EBIT₹-1.15 Cr
Last Qtr PAT₹-1.28 Cr
Last Qtr EBITDA₹0.66 Cr
Last Qtr EBIT₹0.64 Cr
Profitability
ROE
ROCE
TTM NPM10.65%
TTM EBITDA %-14.80%
Curr OPM32.94%
Last OPM-516.13%
Curr NPM
Last NPM
Curr EPS₹0.74
Last EPS₹-0.48
Balance sheet
Equity
Reserve
Total Debt₹0.00 Cr
D/E
Interest %0.00%
Curr Interest₹0.00 Cr
Price / range
Close₹125.30
vs 52W High-31.15%
vs 52W Low+26.31%
MA50
MA200
Returns
1D+1.21%
1W-1.38%
1M+6.19%
3M-6.53%
6M+4.42%
1Y-8.10%
2Y+4.42%
3Y+35.90%
5Y+436.62%
Diwali-3.32%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr148.173.58%
DIVISLAB9375.00₹2.49L Cr84.6217.55%
TORNTPHARM4840.00₹1.84L Cr78.8025.43%
ZYDUSLIFE1160.00₹1.16L Cr33.2112.96%
CIPLA1394.50₹1.13L Cr36.648.93%
LAURUSLABS1954.00₹1.06L Cr120.9216.46%
AUROPHARMA1734.00₹99.77K Cr38.796.84%
DRREDDY1185.00₹98.91K Cr148.681.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue2.57+30.5%0.252.711.701.976.63
Other Income0.211.760.220.200.192.37
Total Income2.78+29.3%2.012.931.902.158.99
Interest00.0100.020.010.03
Expenditure-1.93-7.2%-3.28-1.96-1.24-1.80-8.31
PBDT000000
EBITDA0.66+230.0%-30.770.500.20-1.58
Depreciation-0.02-0.02-0.02-0.02-0.02-0.07
EBIT0.64+255.6%-3.020.750.480.18-1.65
PBT0.85+174.2%-1.280.950.660.310.65
Tax00.73-0.24-0.1700.24
Equity000000
OPM32.94-516.1335.1238.9215.967.00
Net Profit0.85+254.2%-1.280.710.490.240.89
NPM32.94-516.1326.1828.9811.9410.00
EPS0.74-0.480.620.4300.77

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue6.63-5.6%7.02-5.6%7.44-0.4%7.47+4.5%7.15+201.7%2.37
Other Income2.370.710.540.370.160.07
Total Income8.99+16.3%7.73-3.1%7.98+1.7%7.85+7.4%7.31+199.6%2.44
Expenditure-8.31-43.3%-5.80-4.9%-5.53+11.1%-6.22+4.7%-6.53-77.0%-3.69
Interest-0.03-0.02-0.14-0.25-0.71-0.83
PBDT000000
EBITDA-1.58-221.5%1.30-38.4%2.11+34.4%1.57+13.8%1.38+406.7%-0.45
Depreciation-0.07-0.06-0.06-0.07-0.05-0.04
EBIT-1.65-233.1%1.24-39.5%2.05+36.7%1.50+12.8%1.33+371.4%-0.49
PBT0.65-65.1%1.86-24.1%2.45+50.3%1.63+109.0%0.78+162.4%-1.25
Tax0.24-0.40-0.62-0.42-0.240.12
Equity000000
OPM (%)7.0024.0031.0021.0011.00-51.00
Net Profit0.89-36.4%1.40-23.1%1.82+50.4%1.21+124.1%0.54+147.8%-1.13
NPM (%)10.0018.0023.0015.007.00-46.00
EPS (Rs)0.77-36.4%1.21-23.9%1.59+45.9%1.09+70.3%0.64+148.1%-1.33
CEPS0.771.211.591.090.64-1.33

Consolidated

16 lines · 6 periods
MetricDec-25Sep-25Jun-25Mar-25Dec-24FY24-25
Revenue62.94+56.5%62.6053.3849.0440.22187.74
Other Income0.970.630.190.430.191.68
Total Income63.91+58.2%63.2353.5649.4640.41189.41
Interest01.401.221.281.235.39
Expenditure-59.52-52.8%-58.03-49.10-45.50-38.96-173.70
PBDT000000
EBITDA3.42-20.1%8.077.446.654.2826.81
Depreciation0-2.10-1.94-1.83-1.79-7.38
EBIT3.42+37.3%5.975.504.822.4919.43
PBT3.25+124.1%5.214.463.951.4515.67
Tax-0.53-1.58-1.10-1-0.24-4.10
Equity000000
OPM5.098.238.327.993.588.27
Net Profit2.72+124.8%3.623.282.931.2111.54
NPM4.255.736.115.923.006.09
EPS0-100.0%3.152.852.551.0610.05

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 5 years
MetricFY 24-25FY 23-24FY 21-22FY 20-21FY 19-20
Revenue187.74-0.5%188.71163.03+82.1%89.52-6.1%95.32
Other Income1.680.820.330.210.66
Total Income189.41-0.1%189.53163.36+82.1%89.73-6.5%95.98
Expenditure-173.70+2.1%-177.48-151.10-68.2%-89.81+8.3%-97.94
Interest-5.39-5.35-5.23-5.08-4.60
PBDT00000
EBITDA26.81+13.9%23.5423.03+131.5%9.95+54.5%6.44
Depreciation-7.38-6.96-5.87-5.16-4.46
EBIT19.43+17.2%16.5817.16+258.2%4.79+141.9%1.98
PBT15.67+30.0%12.0512.26+15425.0%-0.08+95.9%-1.97
Tax-4.10-2.43-4.01-0.28-0.95
Equity00000
OPM (%)8.276.367.51-0.09-2.05
Net Profit11.54+19.8%9.638.26+2394.4%-0.36+87.7%-2.92
NPM (%)6.095.085.06-0.40-3.04
EPS (Rs)10.05+19.9%8.389.70+2409.5%-0.42+87.8%-3.43
CEPS10.058.389.70-0.42-3.43

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

0

No dividend history.

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers